XENETIC BIOSCIENCES INC (XBIO) Stock Income Statement
NASDAQ:XBIO - Nasdaq - US9840156023 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.58M | 2.50M | 2.54M | 1.71M | 1.16M | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 6.46M | 6.00M | 7.06M | 8.42M | 6.91M | |||
| Research and Development | 3.22M | 2.58M | 3.49M | 4.77M | 3.16M | |||
| Selling, General, and Administrative Expenses | 3.24M | 3.42M | 3.56M | 3.65M | 3.74M | |||
| Operating Income | -3.88M | -3.50M | -4.52M | -6.72M | -5.75M | |||
| Interest Income/Expense | 215.90K | 249.90K | 355.80K | 170.00K | 100.00K | |||
| Other Income/Expense | -5.60K | -5.70K | 25.40K | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | -704.40K | N/A | N/A | 0.00 | |||
| Income Before Taxes | -3.67M | -3.96M | -4.13M | -6.55M | -5.65M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -3.67M | -3.96M | -4.13M | -6.55M | -5.65M | |||
| EBITDA | N/A | N/A | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.38 | -2.57 | -2.71 | -4.61 | -5.49 | |||
| Non GAAP EPS | -2.38 | -2.57 | -2.75 | -4.70 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | -142.03% | -158.39% | -162.78% | -383.04% | -487.07% | |||
| Operating Profit Margin | -150.17% | -139.98% | -177.78% | -392.98% | -495.69% | |||
All data in USD